001     144843
005     20240229112639.0
024 7 _ |a 10.1016/j.ccell.2019.08.001
|2 doi
024 7 _ |a pmid:31526758
|2 pmid
024 7 _ |a 1535-6108
|2 ISSN
024 7 _ |a 1878-3686
|2 ISSN
024 7 _ |a altmetric:66696140
|2 altmetric
037 _ _ |a DKFZ-2019-02268
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a O'Connor, Tracy
|0 P:(DE-HGF)0
|b 0
|e First author
245 _ _ |a Age-Related Gliosis Promotes Central Nervous System Lymphoma through CCL19-Mediated Tumor Cell Retention.
260 _ _ |a New York, NY
|c 2019
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1572868466_10481
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a DKFZ-ZMBH Alliance
520 _ _ |a How lymphoma cells (LCs) invade the brain during the development of central nervous system lymphoma (CNSL) is unclear. We found that NF-κB-induced gliosis promotes CNSL in immunocompetent mice. Gliosis elevated cell-adhesion molecules, which increased LCs in the brain but was insufficient to induce CNSL. Astrocyte-derived CCL19 was required for gliosis-induced CNSL. Deleting CCL19 in mice or CCR7 from LCs abrogated CNSL development. Two-photon microscopy revealed LCs transiently entering normal brain parenchyma. Astrocytic CCL19 enhanced parenchymal CNS retention of LCs, thereby promoting CNSL formation. Aged, gliotic wild-type mice were more susceptible to forming CNSL than young wild-type mice, and astrocytic CCL19 was observed in both human gliosis and CNSL. Therefore, CCL19-CCR7 interactions may underlie an increased age-related risk for CNSL.
536 _ _ |a 316 - Infections and cancer (POF3-316)
|0 G:(DE-HGF)POF3-316
|c POF3-316
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Zhou, Xiaolan
|b 1
700 1 _ |a Kosla, Jan
|0 P:(DE-He78)33b934913c8f151747add87b9420db4c
|b 2
|u dkfz
700 1 _ |a Adili, Arlind
|b 3
700 1 _ |a Garcia Beccaria, Maria
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Kotsiliti, Elena
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Pfister, Dominik
|0 P:(DE-He78)bbf66dc6580ea5b6a0397bca8bb268d4
|b 6
|u dkfz
700 1 _ |a Johlke, Anna-Lena
|b 7
700 1 _ |a Sinha, Ankit
|b 8
700 1 _ |a Sankowski, Roman
|b 9
700 1 _ |a Schick, Markus
|b 10
700 1 _ |a Lewis, Richard
|b 11
700 1 _ |a Dokalis, Nikolaos
|b 12
700 1 _ |a Seubert, Bastian
|b 13
700 1 _ |a Höchst, Bastian
|b 14
700 1 _ |a Inverso, Donato
|0 P:(DE-He78)a2d0ba20ff9bcfeccbdab04513fbf8f0
|b 15
|u dkfz
700 1 _ |a Heide, Danijela
|0 P:(DE-He78)92c93319837b4b915db8393795faf0b6
|b 16
|u dkfz
700 1 _ |a Zhang, Wenlong
|b 17
700 1 _ |a Weihrich, Petra
|b 18
700 1 _ |a Manske, Katrin
|b 19
700 1 _ |a Wohlleber, Dirk
|b 20
700 1 _ |a Anton, Martina
|b 21
700 1 _ |a Hoellein, Alexander
|b 22
700 1 _ |a Seleznik, Gitta
|b 23
700 1 _ |a Bremer, Juliane
|b 24
700 1 _ |a Bleul, Sabine
|b 25
700 1 _ |a Augustin, Hellmut G
|0 P:(DE-He78)2e92d0ae281932fc7347d819fec36b0b
|b 26
|u dkfz
700 1 _ |a Scherer, Florian
|b 27
700 1 _ |a Koedel, Uwe
|b 28
700 1 _ |a Weber, Achim
|b 29
700 1 _ |a Protzer, Ulrike
|b 30
700 1 _ |a Förster, Reinhold
|b 31
700 1 _ |a Wirth, Thomas
|b 32
700 1 _ |a Aguzzi, Adriano
|b 33
700 1 _ |a Meissner, Felix
|b 34
700 1 _ |a Prinz, Marco
|b 35
700 1 _ |a Baumann, Bernd
|b 36
700 1 _ |a Höpken, Uta E
|b 37
700 1 _ |a Knolle, Percy A
|b 38
700 1 _ |a von Baumgarten, Louisa
|b 39
700 1 _ |a Keller, Ulrich
|b 40
700 1 _ |a Heikenwälder, Mathias
|0 P:(DE-He78)66ed2d4ec9bc11d29b87ac006adf85e5
|b 41
|e Last author
|u dkfz
773 _ _ |a 10.1016/j.ccell.2019.08.001
|g Vol. 36, no. 3, p. 250 - 267.e9
|0 PERI:(DE-600)2074034-7
|n 3
|p 250 - 267.e9
|t Cancer cell
|v 36
|y 2019
|x 1535-6108
909 C O |p VDB
|o oai:inrepo02.dkfz.de:144843
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)33b934913c8f151747add87b9420db4c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)bbf66dc6580ea5b6a0397bca8bb268d4
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-He78)a2d0ba20ff9bcfeccbdab04513fbf8f0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 16
|6 P:(DE-He78)92c93319837b4b915db8393795faf0b6
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 26
|6 P:(DE-He78)2e92d0ae281932fc7347d819fec36b0b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 41
|6 P:(DE-He78)66ed2d4ec9bc11d29b87ac006adf85e5
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-316
|2 G:(DE-HGF)POF3-300
|v Infections and cancer
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2019
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER CELL : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 20
|0 StatID:(DE-HGF)9920
|2 StatID
|b CANCER CELL : 2017
920 1 _ |0 I:(DE-He78)F180-20160331
|k F180
|l Chronische Entzündung und Krebs
|x 0
920 1 _ |0 I:(DE-He78)A190-20160331
|k A190
|l Vaskuläre Onkologie und Metastasierung
|x 1
920 1 _ |0 I:(DE-He78)L101-20160331
|k L101
|l DKTK Heidelberg
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)F180-20160331
980 _ _ |a I:(DE-He78)A190-20160331
980 _ _ |a I:(DE-He78)L101-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21